Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 16/20 | 0.54 |
| ▸ | TRAP1 | Q12931 | 4/20 | 0.54 |
| ▸ | HSP90AB1 | P08238 | 12/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.36 |
| ▸ | HSP90B1 | P14625 | 2/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14568045 | 0.87 | HSP90AA1 (0.71) | HSP90AA1TRAP1HSP90AB1HSP90B1 | |
| SCHEMBL14568041 | 0.83 | HSP90AA1 (0.78) | HSP90AA1TRAP1HSP90AB1HSP90B1 | |
| SCHEMBL13539444 | 0.82 | HSP90AA1 (0.54) | HSP90AA1TRAP1HSP90AB1HSP90B1SLC2A1 | |
| SCHEMBL14567912 | 0.82 | HSP90AA1 (0.48) | HSP90AA1TRAP1HSP90AB1ADORA2AADORA1 | |
| SCHEMBL14568296 | 0.81 | HSP90AA1 (0.63) | HSP90AA1TRAP1HSP90AB1ADORA2AADORA1 | |
| SCHEMBL14568050 | 0.80 | HSP90AA1 (0.58) | HSP90AA1TRAP1HSP90AB1ADORA2AADORA1 | |
| SCHEMBL14438225 | 0.78 | HSP90AB1 (0.69) | HSP90AA1TRAP1HSP90AB1HSP90B1 | |
| SCHEMBL14568051 | 0.78 | HSP90AA1 (0.56) | HSP90AA1TRAP1HSP90AB1ADORA2AADORA1 | |
| SCHEMBL13539683 | 0.77 | HSP90AA1 (0.64) | HSP90AA1TRAP1HSP90AB1HSP90B1 | |
| SCHEMBL14567876 | 0.77 | HSP90AA1 (0.60) | HSP90AA1TRAP1HSP90AB1ADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007035963-A2 | ANTI-TUMOR METHODS USING MULTI DRUG RESISTANCE INDEPENDENT SYNTHETIC HSP90 INHIBITORS | CONFORMA THERAPEUTICS CORPORATION (US) | 2007-03-29 | — | — | WO | disclosed |